StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Glucotrack's enterprise value was $3.16M on Oct 19, 2026, against $77.73M a year earlier. Over the last 5 years it ranged from -$3.53M to $19.31B, with a median of $1.47B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$3.16M-92.9%
2025Dec 31, 2025$44.34M-93.1%
2024Dec 31, 2024$645.54M-60.5%
2023Dec 29, 2023$1.64B-75.0%
2022Dec 30, 2022$6.54B-66.1%
2021Dec 31, 2021$19.31B-99.9%
2020Dec 31, 2020$21.39T-26.7%
2019Dec 31, 2019$29.20T+2093.8%
2018Dec 31, 2018$1.33T-66.0%
2017Dec 29, 2017$3.92T-11.8%
2016Dec 30, 2016$4.44T-23.9%
2015Dec 31, 2015$5.83T-39.0%
2014Dec 31, 2014$9.56T-29.3%
2013Dec 31, 2013$13.53T–

More Glucotrack figures

See a number that looks wrong?